February 20, 2025 - 19:39

Stellantis has announced the development of an innovative in-house automated driving platform designed specifically for urban environments. This cutting-edge technology aims to enhance the commuting experience for city dwellers, addressing the unique challenges of navigating busy streets and heavy traffic.
The new platform leverages advanced algorithms and sensor technologies to facilitate safe and efficient driving in complex city landscapes. With features tailored for urban settings, the system is equipped to handle various scenarios, such as pedestrian crossings, cyclists, and unpredictable traffic patterns. The automaker emphasizes that this technology is not just about automation; it also focuses on improving overall road safety and reducing congestion.
As cities continue to grow and traffic becomes increasingly congested, Stellantis's commitment to developing this automated driving solution reflects a proactive approach to meet the evolving needs of urban commuters. The company is optimistic that this technology will revolutionize the way people navigate city life, making it more convenient and stress-free.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...